Aberrations in the Hedgehog signaling pathway, particularly in the activity of SMO, can lead to uncontrolled cell growth and cancer. Mutations or overexpression of SMO have been implicated in various cancers, including basal cell carcinoma (BCC), medulloblastoma, and other solid tumors. These abnormalities can result in the constitutive activation of the pathway, promoting oncogenesis.
